Research in Motion: Doug Bayliss, PhD
5/14/2024
Our lab is interested in the electrical and chemical signals in the brain that control brain function, in particular in areas of the brain that regulate breathing. —Doug Bayliss, PhD,…
UVA School of Medicine Opens Full Service Clinical Trials Unit
5/14/2024
On May 20, National Clinical Trials Day, UVA School of Medicine will celebrate the development of a new, full-service Clinical Trials Unit (CTU) to help UVA School of Medicine,…
5/7/2024
UVA Internal Medicine residents participating in the Health Equity, Advocacy, and Leadership (HEAL) track embarked on a transformative journey to Washington, D.C. on April 11, under the guidance of Cameron…
5/7/2024
Uta Erdbrügger, MD, an associate professor in the Department of Medicine, Division of Nephrology, and colleagues were awarded a five-year, $3.5 million NIH-NIDDK R01 grant titled “Insulin, Extracellular Vesicles, Exercise…
Research in Motion: Robert Dreicer, MD
5/7/2024
As a clinical investigator of patients with urologic cancers, I have the privilege of both caring for these patients as well as being involved in development of new therapies for…
Venable Elementary Students Dive into the World of Science at UVA School of Medicine
5/1/2024
Third-grade students from Venable Elementary School embarked on a journey into the world of science during a recent field-trip in April to the Department of Cell Biology at the UVA…
5/1/2024
The National Institutes of Health (NIH) awarded Ling Qi, PhD, two grants totaling $4.2 million for projects that could lead to new therapeutic treatments for metabolic and liver disorders. Dr.…
Research in Motion: Anita Clayton, MD
5/1/2024
I've helped develop treatments for major depressive disorder, primarily monoamine reuptake inhibitors, but most recently for postpartum depression with novel mechanisms of action, including allopregnanolone analogs, and psychedelics, specifically psilocybin…
